scispace - formally typeset
K

Kazuo Tsubota

Researcher at Keio University

Publications -  1421
Citations -  57308

Kazuo Tsubota is an academic researcher from Keio University. The author has contributed to research in topics: Cornea & Visual acuity. The author has an hindex of 105, co-authored 1379 publications receiving 48991 citations. Previous affiliations of Kazuo Tsubota include Chiba University & Showa University.

Papers
More filters
Journal ArticleDOI

Evaluation of a Thermosensitive Atelocollagen Punctal Plug Treatment for Dry Eye Disease

TL;DR: The preheating method was found to be useful to strengthen the efficacy of the thermosensitive atelocollagen punctal plug in the treatment of dry eye disease.
Journal Article

Suppression of nuclear factor kappa B and CD18-mediated leukocyte adhesion to the corneal endothelium by dexamethasone.

TL;DR: Leukocyte adhesion to the corneal endothelium was shown to be mediated by CD18 expressed on activated leukocytes, and dexamethasone directly suppresses adhesion by inhibiting activation of nuclear factor kappa B.
Journal ArticleDOI

Adherence to Eye Drops Usage in Dry Eye Patients and Reasons for Non-Compliance: A Web-Based Survey

TL;DR: Most participants did not instill the DED eye drops at the specified frequency to alleviate symptoms, and ophthalmologists need to impress upon patients the importance of regular instillation at the frequency specified in the package insert, while taking into account patient characteristics.
Journal ArticleDOI

Comparison of clinical outcomes among 3 marking methods for toric intraocular lens implantation

TL;DR: The refractive and visual results of toric IOL implantation using the 3-point marking method were comparable to the other methods evaluated in this study, although the accuracy of the axis alignment of the toricIOLs was significantly lower than that obtained with the iris pattern method.
Journal ArticleDOI

Ocular Surface and Tear Film Characteristics in a Sclerodermatous Chronic Graft-Versus-Host Disease Mouse Model.

TL;DR: The constellation of these findings suggests that the sclerodermatous cGVHD mouse model well recapitulates ocular manifestations of cGV HD in humans and can be used to study the mechanisms involved in the pathogenesis and treatment of chronic ocular graft-versus-host disease.